Introduction The purpose of the present guidelines on the radioiodine therapy (RAIT) of
differentiated thyroid cancer (DTC) formulated by the European Association of Nuclear …

In the past decade, the management of differentiated thyroid cancer (DTC) underwent a
paradigm shift toward the use of risk stratification with the goal of maximizing the benefit and …

Background: The American Thyroid Association (ATA) management guidelines for patients
with thyroid nodules and differentiated thyroid cancer (DTC) are highly influential practice …

Background: The utility of radioiodine (RAI) scans prior to 131I ablation is controversial. The
objective of this study was to evaluate the utility of RAI scans prior to 131I ablation in patient …

This is a comprehensive presentation of the risks and benefits of radioiodine-131 in the
treatment of metastatic well differentiated thyroid cancer. In addition, methods to optimize the …

For almost five decades, 131I treatment of thyroid cancer has been based empirically on
administered activity rather than on actual radiation doses delivered. In 1983, we defined …

THERAPY OF THYROID DISEASE WITH 131I• Silberstein et al. 1633 patients throughout
the United States. Existing practice guidelines will be reviewed for revision or renewal, as …

Background: The management of aggressive and progressing metastatic differentiated
thyroid cancer (DTC) is very difficult, and the determination as to when such patients are …

GENERAL aspects of the diagnosis and management of differentiated thyroid carcinoma
(DTC) have been reviewed recently (1) and guidelines for management proposed (2). Yet …

Treatment in Differentiated Thyroid Carcinoma Page 1 Predicting the Efficacy of First Iodine—131
Treatment in Differentiated Thyroid Carcinoma Jean-Pierre Muratet. Philippe Giraud, Alain …